Troculeucel: all 41 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Open-Label Extension Protocol to SNK01-AD01 StudyRecruitingNCT07228078Phase 2
- Clinical Study of SNK01 in Participants With Moderate Alzheimer's DiseaseRecruitingNCT06189963Phase 1/2
- Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid TumorsTerminatedNCT02100891Phase 2Results posted
- Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid MalignanciesCompletedNCT01181258Phase 2Results posted
- Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)TerminatedNCT01106950Phase 2Results posted
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast CancerCompletedNCT01105650Phase 2Results posted
- Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic LeukemiaTerminatedNCT00625729Phase 1/2Results posted
- Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell TransplantCompletedNCT00303667Phase 1/2Results posted
- Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing CancersTerminatedNCT05099549Phase 1/2
- A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor TreatmentStatus unknownNCT04872634Phase 1/2
- Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD)TerminatedNCT04678453Phase 1
- Fase I Clinical Trial on NK Cells for COVID-19Status unknownNCT04634370Phase 1
- Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional TherapyCompletedNCT03941262Phase 1
- Autologous Natural Killer Cells in Subjects With Plaque PsoriasisCompletedNCT03894579Phase 1
- High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal CancerCompletedNCT03008499Phase 1/2
- Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver CancerCompletedNCT03008343Phase 1/2
- High-activity Natural Killer Immunotherapy for Small Metastases of Tongue CancerCompletedNCT03008330Phase 1/2
- High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic CancerCompletedNCT03008304Phase 1/2
- High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung CancerCompletedNCT03007875Phase 1/2
- High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal CancerCompletedNCT03007836Phase 1/2
- High-activity Natural Killer Immunotherapy for Small Metastases of MelanomaCompletedNCT03007823Phase 1/2
- Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid TumorsCompletedNCT02857920Phase 1/2
- Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid TumorsCompletedNCT02853903Phase 2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue CancerCompletedNCT02849379Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Recurrent SarcomaCompletedNCT02849366Phase 1/2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian CancerCompletedNCT02849353Phase 1/2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical CancerCompletedNCT02849340Phase 1/2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal CancerCompletedNCT02849327Phase 1/2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal CancerCompletedNCT02849314Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted LiverCompletedNCT02849015Phase 1/2
- Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung CancerCompletedNCT02845856Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Breast CancerCompletedNCT02844335Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung CancerCompletedNCT02843815Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Liver CancerCompletedNCT02843802Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney CancerCompletedNCT02843607Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal CancerCompletedNCT02843581Phase 1/2
- Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid TumorsCompletedNCT02843204Phase 1/2
- Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast CancerCompletedNCT02843126Phase 1/2
- Combination of Rituximab and NK Immunotherapy for B LymphomaCompletedNCT02843061Phase 1/2
- Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid LeukemiaStatus unknownNCT02809092Phase 1/2
- Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory NeuroblastomaCompletedNCT01576692Phase 1